Analyst Price Target is $56.00
▲ +80.53% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Lycia Therapeutics in the last 3 months. The average price target is $56.00, with a high forecast of $75.00 and a low forecast of $43.00. The average price target represents a 80.53% upside from the last price of $31.02.
Current Consensus is
Buy
The current consensus among 4 contributing investment analysts is to buy stock in Lycia Therapeutics.